Table 2. Smoking-related measures, tobacco and anti-tobacco advertising for smokers and quitters.
Smokers (N=631) | Quitters (N=52) | Total (N=683) | p-value | |
---|---|---|---|---|
Smoking-related measures | ||||
Having a smoking partner | 151 (24.0%) | 7 (13.5%) | 158 (23.2%) | 0.084 |
Age began smoking | 15.2 (4.48) | 14.9 (4.04) | 15.1 (4.44) | 0.738 |
Reasons affecting smoking/quitting | ||||
Treatment program requirements | 0.550 | |||
Not at all/a little | 516 (82.2%) | 41 (78.9%) | 557 (81.9%) | |
Somewhat/a lot | 112 (17.8%) | 11 (21.2%) | 123 (18.1%) | |
Cost of a pack of cigarettes | 0.490 | |||
Not at all/a little | 369 (58.8%) | 28 (53.9%) | 397 (58.4%) | |
Somewhat/a lot | 259 (41.2%) | 24 (46.2%) | 283 (41.6%) | |
Health concerns | <.001 | |||
Not at all/a little | 293 (46.7%) | 8 (15.4%) | 301 (44.3%) | |
Somewhat/a lot | 335 (53.3%) | 44 (84.6%) | 379 (55.7%) | |
Family pressure/encouragement/being a good role model | 0.151 | |||
Not at all/a little | 413 (65.7%) | 29 (55.8%) | 442 (64.9%) | |
Somewhat/a lot | 216 (34.3%) | 23 (44.2%) | 239 (35.1%) | |
Warning labels on cigarette packages | 0.561 | |||
Not at all/a little | 511 (81.4%) | 44 (84.6%) | 555 (81.6%) | |
Somewhat/a lot | 117 (18.6%) | 8 (15.5%) | 125 (18.4%) | |
Used cessation products | ||||
Used any NRT1 product | 319 (51.0%) | 25 (49.0%) | 344 (50.9%) | 0.781 |
Used any oral medication | 74 (12.2%) | 7 (13.7%) | 81 (12.3%) | 0.745 |
Used e-cigarettes/vape pens | 282 (45.9%) | 24 (47.1%) | 306 (46.0%) | 0.876 |
Advertising receptivity | 0.485 | |||
High receptivity | 394 (62.4%) | 35 (67.3%) | 429 (62.8%) | |
Moderate/Low receptivity | 237 (37.6%) | 17 (32.7%) | 254 (37.2%) | |
Anti-tobacco message awareness | 0.271 | |||
Daily | 74 (11.7%) | 7 (13.5%) | 81 (11.9%) | |
Weekly | 123 (19.5%) | 7 (13.5%) | 130 (19.0%) | |
Less than once a week | 118 (18.7%) | 15 (28.8%) | 133 (19.5%) | |
Not at all | 316 (50.1%) | 23 (44.2%) | 339 (49.6%) | |
Health risk perception | 62.2 (20.44) | 69.7 (21.10) | 62.8 (20.57) | 0.011 |
NRT refers to nicotine replacement therapy